Efficacy of Pfizer's weight-loss drug 'inferior' to others on the market, says UBS's Colin Bristow

Efficacy of Pfizer's weight-loss drug 'inferior' to others on the market, says UBS's Colin Bristow

PT3M19S | Video has closed captioning.

2024-12-04T10:39:49+0800

Colin Bristow, UBS managing director, joins 'Fast Money' to discuss Pfizer's weight-loss drug. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi  » Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision » Subscribe to CNBC: https://cnb.cx/SubscribeCNBC Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide. Connect with CNBC News Online Get the latest news: http://www.cnbc.com/ Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC https://www.cnbc.com/select/best-credit-cards/  #CNBC #CNBCTV